pancreatic cancer
Bluestar Genomics Raises $70M in Series C Funding Round
The San Diego-based early cancer detection firm has also appointed Felix Fang and Craig Venter to its scientific advisory board.Â
The firm said that recent validation studies have shown that a positive result with its PanCan-d microarray test could accelerate diagnosis for high-risk individuals.
Interpace, Rutgers, Mass General Sign Deal for Pancreatic Cyst Risk Assessment Biomarker
Interpace said that the novel monoclonal antibody, Das-1, will provide additional data regarding pancreatic cancer risk to guide personalized patient management.Â
New Blood Test Could Identify Pancreatic Cancer Subtypes Responsive to Chemotherapy
The test uses the sTRA biomarker to differentiate between different subtypes of pancreatic cancer, including those that are resistant to chemotherapy.
Wales to Routinely Screen Cancer Patients With Yourgene Elucigene Test
Yourgene will provide its Elucigene DPYD tests to screen approximately 200 patients each month for the next year.